undamentalytics Newsletter
Sign in

Interparfums Inc (IPAR) stock

Add to watchlist

Add holding +

NASDAQ: IPAR Nasdaq Personal Care Products Next results ~November 4, 2026

B Fundamentals grade

Interparfums Inc is a US-listed company in the personal care products industry. Its financial year ends in December.

Stock price today

Loading chart…

Third-party market data · may be delayed

Fair value per share

~$100

Cash-flow model

Base case. Range ~$75–$140 across our lower- and higher-growth cases (0.2%–10.2% a year).

Price vs value

Modestly overvalued

The price is inside our value range, 16% above our base value.

Price used: $119.86, November 2, 2026

Interparfums Inc valuation: adjust assumptions and compare models →

Who’s trading

What company insiders, investment funds and members of Congress have been doing with the stock, from their own filings.

  • Insiders0 buying, 3 selling0 purchases and 3 sales by directors and officers, last 12 monthsInsider trades
  • Funds163 adding, 133 cuttingOf 44 active managers that changed their stake, 21 added; quarter to June 30, 2026Fund buyers and sellers

Value diary

Our note on each quarter Interparfums files

Where Interparfums stands after its latest 10-Q

Revenue for the twelve months to June 2026 was $1.50bn, up 2.9% on a year earlier, faster than the 1.9% growth a quarter earlier. Free-cash-flow margin rose to 16.4% from 13.7% a year earlier. Against its peers on growth, profitability, cash generation and balance sheet, it grades B. It passes 6 of our 6 financial-health checks. Our cash-flow model value is $103 a share, against a share price of $116. At that price, our model says the market is pricing in about 6.9% a year of cash-flow growth for five years, slower than the 11.3% a year revenue growth it has delivered.

Source: 10-Q filed August 4, 2026 on SEC EDGAR · Financials · Valuation

Written from the company's filings and our models when each quarter's report arrives. Figures in older notes are as published at the time. Not investment advice.

The Fundamentalytics view

Next results ~November 4, 2026 (estimated)

Interparfums Inc's trailing-twelve-month revenue grew 2.9% year on year, with a free-cash-flow margin of 16.4%. Where it stands out: stock pay as % of revenue of 0.1% ranks 2 of 18 personal care products companies we cover. Where it lags: days sales outstanding of 73 days ranks 14 of 14 personal care products companies we cover.

Our discounted-cash-flow model values the business at ~$100 per share in the base case (~$75–$140 across growth scenarios) — model values under stated assumptions, not a price target.

Current signal Free cash flow diverging from earnings: TTM free cash flow grew 23.3% while net income grew 4.2%: a 19pp divergence.

Assembled from SEC-filed figures — the full workings are on this page and in our methodology. Observations, not recommendations.

Highlights

How we pick these

Strengths

Nothing in Interparfums Inc's latest figures clears our strength thresholds.

Things to watch

  • Below peers: days sales outstanding. Days sales outstanding of 73 days ranks 14 of 14 personal care products companies we cover (median 33 days).
  • Heavily shorted. 11.4% of the shares available to trade are sold short (9.4 days of average volume to cover).
  • Estimates being cut. Analysts' consensus for next year's earnings per share has fallen 6.8% over 90 days.

Latest results: FY2026 Q2

Filed August 4, 2026
Earnings per share
$0.95 against an average estimate of $0.97: missed by 2.1%
Revenue
$341m, up 2.1% on a year earlier
Share reaction
-1.4% in the first session after the results on October 20, 2026, against +0.9% for the S&P 500
Next report
November 4, 2026; average EPS estimate $1.89

Interparfums' figures from its SEC filings and results release; estimates are the analysts' average. Not a recommendation.

Price chart

  • 1 day+3.0%
  • 1 week+3.9%
  • 1 month+5.2%
  • This year+44.7%
  • 1 year+39.0%
  • 5 years+49.1%
  • S&P 500 this year+11.2%

Closing prices to 2026-11-02. Price change only, dividends excluded.

Loading chart…

Third-party market data · may be delayed

At a glance

Trailing twelve months, from SEC filings

Profitability

Revenue (TTM)
$1.5B
Operating margin
17.3%
Net margin
11.2%
EPS (TTM, diluted)
$5.23

Growth

Revenue growth
+2.9%
Change in growth rate
+1.1 pts
Share count change
−0.0%

Cash

Free cash flow (TTM)
$246M
FCF margin
16.4%
Stock pay % of revenue
0.1%

Earnings

Last results
October 20, 2026

News & updates

Updated October 31, 2026

Company announcements, filed results and changes that matter to shareholders.

  1. Results
  2. Announcement
  3. Announcement
  4. Shareholder vote
  5. Results
  6. Results

Refreshed hourly when new source data is available. Summaries are checked against company releases and SEC filings. Company announcement headlines are labelled when a checked summary is unavailable.

Valuation

Interparfums Inc valuation models and calculator

What the price is pricing in

The share price implies about 7.4% a year of cash-flow growth for five years.That is close to the 11.3% a year revenue growth Interparfums has delivered.

  • Priced in7.4%
  • Last 12 months2.9%
  • 3 years a year7.4%
  • 5 years a year11.3%

Our cash-flow model with every input fixed except growth over the next five years, solved for the growth at which the model value equals the share price ($119.04, Nov 3, 2026). Cash-flow growth then fades to 2.5% a year; discount rate 8.5%. Delivered figures are revenue growth from SEC filings. This is a model exercise, not investment advice or a forecast of the share price. All companies

Fundamentalytics rating

model v1.6 · 2026-11-03
Hold12-month view
12-month price target
~$100
Price used
$119.04close November 3, 2026
Implied change
▼ 14%
Uncertainty
Medium

How we got here: a discounted-cash-flow model of Interparfums Inc's free cash flow after stock-based pay with after-tax interest added back ($183M, FY2026 Q2 TTM), growing 3.6% and 5.7% in the next two years (forecasts, guidance and its record), then back to 5.2% by year five, and fading to 2.5%, discounted at 8.5%. Lower and higher growth cases span ~$75–~$140 ; that spread sets a 25% margin before we rate Buy or Sell.

Produced by Fundamentalytics' automated valuation model on November 3, 2026, using delayed market prices. Rating meanings, methodology and conflicts: recommendations disclosure and research disclaimer. General research, not personal advice — it does not consider your circumstances. Prices can fall as well as rise.

Our value per share comes from a discounted-cash-flow model of Interparfums Inc's free cash flow after stock-based pay ( $183M, FY2026 Q2 TTM, with after-tax interest added back): growth for five years as below (the first two years from forecasts, guidance and the company's record), fading to 2.5%, discounted at 8.5%, then cash added and debt and other claims subtracted. These are model values under stated assumptions, not price targets or recommendations.

Valuation models

We value Interparfums Inc as an operating company, with every model that fits that kind of business. Cost of equity 7.8%: the 10-year Treasury yield (4.9%) plus a beta of 0.63 times a 4.5% equity risk premium.

Value per share by model
Model Value per share In the combined value?
Cash-flow model (DCF) Free cash flow to the firm (after stock pay, with after-tax interest added back), grown then faded to 2.5%, discounted at 8.5% as the firm rate, less debt and other claims. ~$100 ~$75–$140 Primary model, counts double
Forward price-to-earnings vs peers Next year's consensus earnings per share times peers' typical (harmonic-mean) forward price-to-earnings. Uses analysts' consensus estimates (third-party data), not our forecasts. ~$86 ~$76–$130 Included
Residual income Book value plus the present value of returns above the cost of equity, fading over ten years. ~$81 ~$61–$110 Included
Justified price-to-book Book value times (return on equity - growth) / (cost of equity - growth): steady-state returns. ~$99 ~$82–$130 Included
Combined value Weighted average of the models that apply: the primary model (cash-flow model (dcf)) counts double. Models more than 5x or less than 0.2x the share price, or more than 3x away from the other models' median, are left out. ~$94 ~$81–$100 4 models

Different models fail in different ways, so where several apply we average them rather than trust one. Peer-based models compare Interparfums Inc with Personal Care Products in our coverage, using third-party market data. Model values are estimates under stated assumptions, updated as new filings arrive; not price targets or investment advice. How each model works.

What moves the value

  • Revenue growth 5 points lower ▼ −27%
  • Revenue growth 5 points higher ▲ +36%
  • Free-cash-flow margin 1 point lower ▼ −6%
  • Last year's free-cash-flow margin change, if it persists ▲ +21%
  • Discount rate 1 point higher ▼ −15%
Value per share under different assumptions
Discount rate ↓ / growth → −5% growth0% growth5% growth10% growth15% growth20% growth
7% $72$102$141$192$259$346
8.5% $53$74$102$139$187$248
10% $41$58$79$108$144$191

Valuation multiples over time Market data may be delayed

At fiscal year end 20152016201720182019202020212022202320242025Now
Share price$19.28$27.05$36.54$56.03$63.17$52.91$94.72$87.71$133.32$124.72$82.83$119.86
Market value$600m$843m$1.1bn$1.8bn$2.0bn$1.7bn$3.0bn$2.8bn$4.3bn$4.0bn$2.7bn$3.8bn
+ Net debt (− = net cash)−$78m−$87m−$148m−$147m−$110m−$145m−$159.5bn$75m$0$0$0$0
Enterprise value$521m$756m$996m$1.6bn$1.9bn$1.5bn−$156.4bn$2.9bn$4.3bn$4.0bn$2.7bn$3.8bn
Multiples
Price / sales 1.3x1.6x1.9x2.6x2.8x3.1x3.4x2.6x3.3x2.8x1.8x2.6x
Price / earnings 19.7x25.3x27.5x32.8x33.2x43.8x34.5x23.2x28.1x24.4x15.8x22.9x
Price / free cash flow 13.1x16.9x34.8x29.9x28.2x31.0x—71.4x43.1x21.9x14.0x15.6x
EV / EBITDA 8.1x10.7x12.1x16.4x17.4x19.3xn/m13.3x15.9x13.2x9.0x13.5x

Market value uses the period's diluted share count; figures for each fiscal year use that year's results and the price at year end. "Now" uses today's price and the last twelve months.

Moat

68 /100

Moderate moat

How hard Interparfums's competitive advantage looks for rivals to wear away, judged from 10 years of its own filings: returns on capital, pricing power, profit durability, cash conversion and discipline.

  • Returns on capital 12 / 20

    Cash operating profit has been a median 9.6% of total assets over 10 years.

  • Pricing power 20 / 20

    Gross margin has been a median 63.3%, moving by 0.8 percentage points (standard deviation) across 10 years.

  • Durability 14 / 20

    Operating margin has been a median 17.0%; its worst year was 10.9%.

  • Cash conversion 13 / 20

    Free cash flow was positive in 9 of 10 years, at a median 8.3% of revenue.

AI disruption exposure: Medium. In this industry, AI could change how the product is made or sold, without replacing the core asset. The score above includes a 5-point deduction for that exposure (73 before it).

A rules-based reading of reported figures, not a forecast and not investment advice. How the score is built: methodology.

Forecasts and guidance

Next results: November 4, 2026, after the close. Analysts expect revenue of $424m and EPS of $1.89 (range $1.87 to $1.93) for the quarter.

Analysts' consensus

Fiscal yearEPSGrowthRevenueGrowth
Current $4.89 −7% $1.5bn 0%
Next $5.20 +6% $1.6bn +7%

Next year's EPS estimate has moved −6.8% in 90 days, across 5 analysts.

Earnings against estimates

Quarter toEstimateActualSurprise
Jun 2026 $0.97 $0.95 −2.1%
Mar 2026 $1.18 $1.35 +14.4%
Dec 2025 $0.78 $0.88 +12.8%
Sept 2025 $1.93 $2.05 +6.2%

Adjusted EPS as companies report it, against the average analyst estimate.

Management guidance

Earnings release, October 20, 2026

No numeric guidance in Interparfums Inc's latest earnings release (filed October 20, 2026). Some companies give their outlook only on the earnings call.

How our valuation uses these forecasts

Our cash-flow model grows Interparfums Inc's revenue by +3.6% next year and +5.7% the year after, then fades back toward its own record by year five. Next year's rate weighs analysts' consensus (+2.7%, weight 64%) and the company's own record (+5.2%, weight 36%) . How the weights are set.

Analyst recommendations

6 analysts, Oct 2026
Buy233%
Hold350%
Sell117%

Monthly trend

  1. Oct 20262316
  2. Sep 20262316
  3. Aug 20262316
  4. Jul 202655

Counts of recommendations published by analysts covering Interparfums Inc, by month. Source: Aggregated broker recommendations (third-party data). Aggregated counts only: we do not reproduce any firm's recommendation or price target, and these are not Fundamentalytics ratings.

Positioning

Short interest
11.4%
of tradable shares
Days to cover
9.42
at average volume
Short interest, 1 month
+5%
to September 30, 2026
Held by institutions
69%
of shares
Held by insiders
43.6%
of shares
Employees
662
full time

Consensus figures average analysts' published estimates (third-party data); guidance is the company's own. Neither is our forecast. Short interest is reported twice a month and lags. Market data may be delayed.

This section is general information, not investment advice or a personal recommendation, and it does not take account of your objectives or circumstances. Forecasts and guidance are estimates, not promises: companies miss their own guidance and analysts' figures are often revised. Prices can fall as well as rise, and you can lose money. See our disclaimer.

Share-price performance

Market data may be delayed

What moved the share price

Last 12 months +39.0%

$86.22 on October 31, 2025 to $119.86

ThenNowEffect
Revenue (last 12 months) $1.5bn $1.5bn +2.9%
Net margin 11.0% 11.2% +1.3%
P/E multiple 17.2x 22.9x +33.4%
Share count 32m 32m 0.0%

Biggest factor: p/e multiple.

Last 3 years +0.1%

$119.72 on November 3, 2023 to $119.86

ThenNowEffect
Revenue (last 12 months) $1.2bn $1.5bn +23.9%
Net margin 12.1% 11.2% −7.9%
P/E multiple 26.1x 22.9x −12.2%
Share count 32m 32m 0.0%

Biggest factor: revenue.

The effects multiply back to the price change exactly. Results are the last 12 months as known on each date (filings assumed public 45 days after quarter end).

Return and risk by year

Calendar year 202120222023202420252026 to date
Return
IPAR+79%−7%+52%−7%−34%+45%
Industry peers (median)+31%−33%+3%−11%−34%−1%
S&P 500+29%−18%+26%+25%+18%+11%
Months that ended higher
IPAR67%33%58%42%25%73%
S&P 50075%42%67%75%75%46%
Largest fall from a high during the year
IPAR−14%−39%−22%−29%−44%−17%
S&P 500−5%−25%−10%−8%−19%−9%

Worst fall since November 2, 2015: 55% from November 5, 2019 to March 20, 2020. Getting back needed a 122% gain, reached on June 8, 2021, 445 days after the low.

Price behaviour

52-week range
$76.96 – $127.63
From 52-week high
−6.1%
vs 50-day average
+4.8%
vs 200-day average
+15.8%
Volatility (1 year)
30%
Beta vs S&P 500
0.32

Volatility is the annualised standard deviation of daily returns. Beta 1.5 means the shares typically moved 1.5% for each 1% move in the S&P 500 over the past year. Prices to November 2, 2026.

Share price after results

Next day
5 up, 7 down
typical move ±3.5%
After a week
5 up, 7 down
typical move ±3.9%
After a month
2 up, 9 down
typical move ±9.7%
Results releasedNext dayS&P 500 next day5 days21 days
October 20, 2026 −1.4% +0.9% +0.4% —
August 4, 2026 −1.2% +1.6% −3.9% −6.8%
July 22, 2026 −2.5% −1.3% +3.4% −6.6%
May 5, 2026 +5.7% +2.2% +0.5% −0.9%
April 21, 2026 −6.2% +0.4% −6.0% −7.9%
February 24, 2026 −0.1% +1.6% −6.1% −9.5%
January 21, 2026 +7.2% +1.7% +4.3% +13.3%
November 5, 2025 −2.1% −0.7% −1.1% −7.6%
October 20, 2025 +0.9% +1.0% −2.4% −12.8%
August 5, 2025 +0.6% +0.3% −2.9% −4.6%
July 23, 2025 −8.0% +0.9% −7.4% −15.8%
May 5, 2025 +6.2% −1.4% +8.7% +21.3%

From the close before the release date to the close 1, 5 and 21 trading days after it, so releases before the open and after the close are both captured. Past moves don't predict future ones.

Options strategies

All options ideas

How Interparfums Inc’s listed options are priced, and three ways to use them that follow from our valuation. Quotes are delayed, read November 2, 2026. Check the live chain at your broker before trading.

Cash-secured put

Not offered: fundamentals grade B (needs B+ or better).

We suggest selling a put only on well-rated companies, at a strike where the price you would pay if assigned (strike less premium) is at or below our fair value.

Covered call

Not offered: no liquid call at or above our price target — the model says the upside is worth more than any listed strike.

For holders: sell a call at a strike at or above our fair value, so the shares are only sold at a price the model calls full value.

Collar

Not offered: no liquid put and call pair for the same expiry.

For holders of a stock trading at or above our fair value: buy a put for a floor and sell a call to pay for it.

General research, not personal advice. Options can lose you more than you expect and are not suitable for everyone: put sellers can be made to buy shares that keep falling, call sellers give up gains above the strike, and results or news can move prices sharply. Chances shown are approximations from each option’s delta. Spreads, fees and early assignment are not modelled.

Interparfums Inc in five measures

Fundamentals grade B
Growth Profitability Cash Balance sheet Value

Growth, profitability, cash generation and balance sheet are percentiles against the companies we cover in the same industry, from SEC filings (100 = best). Value compares the share price with our modelled value range (50 = at our base value; higher = cheaper). A description of reported data and our model — not a quality score or advice.

Fundamentals

Revenue (TTM) Interparfums Inc
$1.2B $1.3B $1.4B $1.5B $1.6B FY23 Q3 FY24 Q2 FY25 Q1 FY26 Q2 Revenue (TTM), FY23 Q3: $1.3B Revenue (TTM), FY23 Q4: $1.3B Revenue (TTM), FY24 Q1: $1.3B Revenue (TTM), FY24 Q2: $1.4B Revenue (TTM), FY24 Q3: $1.4B Revenue (TTM), FY24 Q4: $1.5B Revenue (TTM), FY25 Q1: $1.5B Revenue (TTM), FY25 Q2: $1.5B Revenue (TTM), FY25 Q3: $1.5B Revenue (TTM), FY25 Q4: $1.5B Revenue (TTM), FY26 Q1: $1.5B Revenue (TTM), FY26 Q2: $1.5B $1.5B

Source: SEC EDGAR filings. Retrieved October 26, 2026.

View chart data
Period Revenue (TTM)
FY23 Q3 $1.3B
FY23 Q4 $1.3B
FY24 Q1 $1.3B
FY24 Q2 $1.4B
FY24 Q3 $1.4B
FY24 Q4 $1.5B
FY25 Q1 $1.5B
FY25 Q2 $1.5B
FY25 Q3 $1.5B
FY25 Q4 $1.5B
FY26 Q1 $1.5B
FY26 Q2 $1.5B
Revenue growth, TTM YoY Interparfums Inc
0% 10% 20% 30% 40% FY23 Q3 FY24 Q2 FY25 Q1 FY26 Q2 Revenue growth, TTM YoY, FY23 Q3: 31.7% Revenue growth, TTM YoY, FY23 Q4: 21.3% Revenue growth, TTM YoY, FY24 Q1: 15.9% Revenue growth, TTM YoY, FY24 Q2: 12.4% Revenue growth, TTM YoY, FY24 Q3: 9.2% Revenue growth, TTM YoY, FY24 Q4: 10.2% Revenue growth, TTM YoY, FY25 Q1: 10.3% Revenue growth, TTM YoY, FY25 Q2: 7.0% Revenue growth, TTM YoY, FY25 Q3: 3.1% Revenue growth, TTM YoY, FY25 Q4: 2.5% Revenue growth, TTM YoY, FY26 Q1: 1.9% Revenue growth, TTM YoY, FY26 Q2: 2.9% 2.9%

Source: SEC EDGAR filings. Retrieved October 26, 2026.

View chart data
Period Revenue growth, TTM YoY
FY23 Q3 31.7%
FY23 Q4 21.3%
FY24 Q1 15.9%
FY24 Q2 12.4%
FY24 Q3 9.2%
FY24 Q4 10.2%
FY25 Q1 10.3%
FY25 Q2 7.0%
FY25 Q3 3.1%
FY25 Q4 2.5%
FY26 Q1 1.9%
FY26 Q2 2.9%
Operating margin (TTM) Interparfums Inc
17% 18% 19% 20% FY23 Q3 FY24 Q2 FY25 Q1 FY26 Q2 Operating margin (TTM), FY23 Q3: 19.7% Operating margin (TTM), FY23 Q4: 19.1% Operating margin (TTM), FY24 Q1: 17.2% Operating margin (TTM), FY24 Q2: 17.5% Operating margin (TTM), FY24 Q3: 18.2% Operating margin (TTM), FY24 Q4: 18.9% Operating margin (TTM), FY25 Q1: 19.2% Operating margin (TTM), FY25 Q2: 18.9% Operating margin (TTM), FY25 Q3: 19.0% Operating margin (TTM), FY25 Q4: 18.2% Operating margin (TTM), FY26 Q1: 18.0% Operating margin (TTM), FY26 Q2: 17.3% 17.3%

Source: SEC EDGAR filings. Retrieved October 26, 2026.

View chart data
Period Operating margin (TTM)
FY23 Q3 19.7%
FY23 Q4 19.1%
FY24 Q1 17.2%
FY24 Q2 17.5%
FY24 Q3 18.2%
FY24 Q4 18.9%
FY25 Q1 19.2%
FY25 Q2 18.9%
FY25 Q3 19.0%
FY25 Q4 18.2%
FY26 Q1 18.0%
FY26 Q2 17.3%
FCF margin (TTM) Interparfums Inc
0% 5% 10% 15% 20% FY23 Q3 FY24 Q2 FY25 Q1 FY26 Q2 FCF margin (TTM), FY23 Q3: 7.7% FCF margin (TTM), FY23 Q4: 7.5% FCF margin (TTM), FY24 Q1: 4.2% FCF margin (TTM), FY24 Q2: 4.9% FCF margin (TTM), FY24 Q3: 8.9% FCF margin (TTM), FY24 Q4: 12.6% FCF margin (TTM), FY25 Q1: 15.5% FCF margin (TTM), FY25 Q2: 13.7% FCF margin (TTM), FY25 Q3: 12.4% FCF margin (TTM), FY25 Q4: 12.8% FCF margin (TTM), FY26 Q1: 13.2% FCF margin (TTM), FY26 Q2: 16.4% 16.4%

Source: SEC EDGAR filings. Retrieved October 26, 2026.

View chart data
Period FCF margin (TTM)
FY23 Q3 7.7%
FY23 Q4 7.5%
FY24 Q1 4.2%
FY24 Q2 4.9%
FY24 Q3 8.9%
FY24 Q4 12.6%
FY25 Q1 15.5%
FY25 Q2 13.7%
FY25 Q3 12.4%
FY25 Q4 12.8%
FY26 Q1 13.2%
FY26 Q2 16.4%

Data: SEC EDGAR XBRL company facts (as filed in 10-K/10-Q); forms 10-K, 10-K/A, 10-Q, 10-Q/A. Generated November 3, 2026. Definitions in our methodology.

Where the money goes

FY2025, from the 10-K

Each dollar Interparfums took in during FY2025, followed through to profit: what it cost to make, what went on running the business, and what was left after tax.

  1. Revenue $1.5B
  2. Cost of revenue $541M · 36.4%
  3. Gross profit $947M · 63.6%
  4. Selling, general and admin $677M · 45.5%
  5. Operating income $270M · 18.2%
  6. Income tax $63.2M · 4.2%
  7. Interest and other $38.7M · 2.6%
  8. Net income $168M · 11.3%

Shares of revenue. Source: Interparfums's 10-K for FY2025, as filed with the SEC. "Other" lines are what the reported lines leave unexplained.

Financial statements

US$ billions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year 2009 Dec 2009 2010 Dec 2010 2011 Dec 2011 2012 Dec 2012 2013 Dec 2013 2014 Dec 2014 2015 Dec 2015 2016 Dec 2016 2017 Dec 2017 2018 Dec 2018 2019 Dec 2019 2020 Dec 2020 2021 Dec 2021 2022 Dec 2022 2023 Dec 2023 2024 Dec 2024 2025 Dec 2025 LTM Jun 2026
Income
Revenue 0.4 0.5 0.6 0.7 0.6 0.5 0.5 0.5 0.6 0.7 0.7 0.5 0.9 1.1 1.3 1.5 1.5 1.5
Gross profit 0.2 0.3 0.4 0.4 0.3 0.3 0.3 0.3 0.4 0.4 0.4 0.3 0.6 0.7 0.8 0.9 0.9 1.0
EBITDA 0.1 0.1 0.1 0.3 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.2 0.3 0.3 0.3 0.3
Operating income 0.0 0.1 0.1 0.3 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.3 0.3 0.3 0.3
Net income 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.1 0.2 0.2 0.2 0.2
Diluted EPS $0.74 $0.87 $1.05 $4.26 $1.27 $0.95 $0.98 $1.07 $1.33 $1.71 $1.90 $1.21 $2.75 $3.78 $4.75 $5.12 $5.24 $5.23
Growth (year on year)
Revenue — +12.4% +33.6% +6.3% −13.8% −11.4% −6.2% +11.2% +13.5% +14.3% +5.6% −24.5% +63.2% +23.6% +21.3% +10.2% +2.5% +2.9%
EBITDA — +7.5% +21.7% +293.5% −70.9% −32.2% +13.8% +9.1% +17.1% +19.9% +9.7% −27.0% +103.1% +34.9% +23.9% +12.8% −2.5% −6.9%
Operating income — +26.0% +18.6% +315.9% −71.7% −32.2% +14.6% +8.9% +17.9% +20.5% +10.6% −33.1% +111.2% +31.2% +29.4% +9.3% −1.6% −6.2%
Net income — +18.9% +21.5% +306.0% −70.1% −24.9% +3.4% +9.5% +24.8% +29.3% +12.0% −36.6% +128.7% +38.4% +26.2% +7.7% +2.5% +4.2%
Diluted EPS — +17.6% +20.7% +305.7% −70.2% −25.2% +3.2% +9.2% +24.3% +28.6% +11.1% −36.3% +127.3% +37.5% +25.7% +7.8% +2.3% +4.2%
Margins
Gross margin 57.2% 59.3% 62.3% 62.3% 58.3% 57.5% 61.8% 62.7% 63.6% 63.3% 62.5% 61.4% 63.3% 63.9% 63.7% 63.9% 63.6% 63.8%
EBITDA margin 13.6% 13.0% 11.9% 43.9% 14.8% 11.4% 13.8% 13.5% 13.9% 14.6% 15.2% 14.7% 18.3% 20.0% 20.4% 20.9% 19.9% 18.9%
Operating margin 10.9% 12.3% 10.9% 42.6% 14.0% 10.7% 13.1% 12.8% 13.3% 14.0% 14.7% 13.0% 16.8% 17.9% 19.1% 18.9% 18.2% 17.3%
Net margin 5.5% 5.8% 5.3% 20.0% 7.0% 5.9% 6.5% 6.4% 7.0% 8.0% 8.4% 7.1% 9.9% 11.1% 11.6% 11.3% 11.3% 11.2%
Free-cash-flow margin 19.3% 6.9% −5.5% 7.8% 7.8% 6.7% 9.8% 9.6% 5.6% 8.7% 10.0% 10.0% −2.5% 3.6% 7.5% 12.6% 12.8% 16.4%
Cash flow
Cash from operations 0.1 0.0 −0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.2 0.3
Capital spending 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0
Free cash flow 0.1 0.0 −0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 −0.0 0.0 0.1 0.2 0.2 0.2
Stock-based pay 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Free cash flow after stock pay 0.1 0.0 −0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 −0.0 0.0 0.1 0.2 0.2 0.2
Balance sheet
Cash 0.1 0.0 0.0 0.3 0.1 0.1 0.2 0.2 0.2 0.2 0.1 0.2 159.6 0.1 — — — —
Total debt 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.1 0.2 0.2 0.2 0.2 0.1
Net debt (negative = net cash) −0.1 −0.0 −0.0 −0.3 −0.1 −0.1 −0.1 −0.1 −0.1 −0.1 −0.1 −0.1 −159.5 0.1 — — — —
Diluted shares 30m 30m 31m 31m 31m 31m 31m 31m 31m 32m 32m 32m 32m 32m 32m 32m 32m 32m
Returned to shareholders
Dividends 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1
Buybacks 0.0 0.0 — 0.0 0.0 0.0 0.0 0.0 — — — — — 0.0 0.0 0.0 0.0 0.0
Total returned 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1

Source: SEC EDGAR XBRL company facts (US and foreign periodic filings); column headings link to the filing. EBITDA is operating income plus depreciation and amortisation. Free cash flow is cash from operations minus capital spending. Growth is left blank when last year's figure was a loss or under 2% of revenue. Share counts and EPS are restated for stock splits. A dash means the company didn't report the figure.

Financial health

6 of 6 checks passed · June 30, 2026
What it owns · $1.5bn
Short-term assets $951mLonger-term assets $539m
What it owes, and who funded it · $1.3bn
Short-term liabilities $287mLonger-term liabilities $112mShareholders' equity $870m
  • Short-term assets cover short-term liabilities $951m of assets due within a year against $287m of liabilities due within a year.
  • Short-term assets cover long-term liabilities $951m short-term assets against $112m of longer-dated liabilities.
  • More cash than debt Cash or debt not separately reported. Not assessable.
  • Debt below 40% of shareholders' equity Debt is 16% of equity.
  • Debt burden no higher than five years ago Debt to equity moved from 23% to 16% over five years.
  • A year's operating cash flow covers at least 20% of debt $256m of operating cash flow against $143m of debt.
  • Operating profit covers interest at least five times over Operating income of $259m against $7m of interest.

From Interparfums Inc's latest balance sheet as filed. Checks are fixed, documented rules (methodology), counted only where the company reports the figures — a dot means the filing doesn't break the item out. Descriptions of reported data, not advice.

Dividends, buybacks and capital spending

FY2026 Q2 TTM
Buybacks (TTM)
$15.8M
Dividends (TTM)
$103M
Returned to shareholders
48%
of free cash flow
Buybacks, last 3 fiscal years
$29.3M
Diluted share count
−0.0%
year over year
Total shareholder yield
3.1%
dividends 2.7% + buybacks 0.4% of market value
Dividend payout ratio
61%
of net income paid out
Sales & admin spending
46.6%
of revenue
Days sales outstanding
73 days
receivables vs revenue

Competitors: side by side with peers

Closest by revenue in personal care products
Last 12 months unless stated IPAR NUS ELF EPC BRBR USNA Median
Revenue, last 12 months $1.5bn $1.4bn $1.8bn $2.2bn $2.4bn $913m $913m
Revenue growth, last 12 months 2.9% −15.4% 31.2% 11.6% 5.9% 1.6% 3.5%
Revenue growth, 3-year average 7.4% −12.3% 37.9% −0.2% 14.4% −1.2% −0.1%
Revenue growth, latest quarter 2.1% −17.1% 35.5% 1.7% 4.2% −5.3% 2.7%
Gross margin 63.8% 69.2% 74.4% 39.5% 28.6% 77.4% 69.2%
Operating margin 17.3% −0.8% 7.2% 0.8% 13.3% −0.1% 6.7%
Operating margin, 3-year average 17.9% −2.8% 10.4% 5.7% 16.1% 5.3% 5.5%
Net margin 11.2% −15.7% 3.4% −4.2% 7.3% −2.4% 3.4%
Cash from operations / revenue 17.1% 3.7% 16.9% 5.4% 9.9% 3.0% 9.9%
Free-cash-flow margin 16.4% 0.8% 15.9% 2.3% 9.6% 1.7% 9.6%
Free-cash-flow margin, 3-year average 11.7% 3.4% 9.8% −10.2% 9.3% 4.7% 6.0%
Stock pay / revenue 0.1% 1.0% 5.5% 0.9% 1.0% 1.6% 1.0%
Change in share count −0.0% 0.1% 3.0% −3.6% −7.9% −2.9% −0.0%

Median of all 21 companies we cover in personal care products. Shaded: best of the six on that line (lowest for stock pay and share-count growth). 3-year figures average the last three 12-month periods; 3-year growth is compound annual. Source: SEC filings.

Peer comparison

21 personal care products companies
Measure Company Peer median Rank
Revenue growth Growth 2.9% 3.5% 13 of 21
Change in growth rate Growth +1.1pp +0.7pp 9 of 21
Gross margin Profitability 63.8% 69.2% 12 of 21
Operating margin Profitability 17.3% 6.7% 4 of 21
Net margin Profitability 11.2% 3.4% 4 of 21
Free-cash-flow margin Cash generation 16.4% 9.6% 4 of 21
Stock pay as % of revenue Cash generation 0.1% 1.0% 2 of 18
Long-term debt as % of assets Balance sheet 6.5% 29.7% 2 of 13
Change in share count Balance sheet -0.0% -0.0% 10 of 19
Days sales outstanding Balance sheet 73 days 33 days 14 of 14

Rank 1 = best in the group (for spending, debt and dilution, lower ranks first).

Where the revenue comes from

Fiscal year to December 31, 2025
Geography
Region Revenue YoY
North America $557M ▲ 2.7%
United States $532M ▲ 2.0%
Western Europe $383M ▲ 5.2%
Asia Pacific $189M ▼ 4.1%
Eastern Europe $121M ▲ 2.5%
Central and South America $121M ▲ 11.5%
Middle East and Africa $118M ▼ 4.0%
France $72.9M ▲ 11.5%

These categories overlap or exclude eliminations, so shares aren't shown.

From Interparfums Inc's 10-K filed March 10, 2026, as tagged in the filing. View filing. Indented rows are part of the line above; their share is of that line. In the bars, the faint bar behind is the year before.

Who owns it

Funds buying and selling
Reported value
$2.4B
Institutions reporting
312
Shares held vs prior quarter
▲ 3.3%
Positions opened / closed
38 / 34

Top buyers and sellers, Q2 2026: 163 institutions bought and 133 sold ; the biggest buyer was Cooke & Bieler LP (+234K shares) and the biggest seller Ameriprise Financial Inc (−125K). See which funds bought and sold →

Largest reported holders, June 30, 2026
Manager Value Shares Share of 13F value Shares QoQ
Blackrock, Inc. $326M 2.9M 13.6% ▲ 6.7%
Morgan Stanley $149M 1.3M 6.2% ▲ 1.4%
Vanguard Portfolio Management LLC $146M 1.3M 6.1% ▲ 3.2%
First Trust Advisors LP $116M 1.0M 4.8% ▲ 17.9%
Westwood Holdings Group Inc $99.1M 886K 4.1% ▼ 11.9%
Dimensional Fund Advisors LP $96.9M 867K 4.0% ▲ 8.8%
Royce & Associates LP $96.7M 864K 4.0% ▲ 5.0%
Vanguard Capital Management LLC $89.2M 797K 3.7% ▲ 1.1%
State Street Corp $83.6M 748K 3.5% ▲ 5.6%
Charles Schwab Investment Management Inc $80.2M 717K 3.3% ▲ 11.7%
Geode Capital Management, LLC $55.1M 493K 2.3% ▲ 5.8%
Victory Capital Management Inc $53.5M 478K 2.2% ▲ 16.2%

From Form 13F filings with the SEC ( quarterly data sets), as reported by each manager for June 30, 2026 and filed up to 45 days later. 13F reports cover long US-listed positions of managers above $100M only, so this is not Interparfums Inc's complete shareholder register. Values are as reported by the filers ; 2 inconsistently scaled filing rows were excluded.

Insider trading activity

Full insider history and chart
Insider purchases History → $0 0 trades by 0 insiders, last 12 months Insider sales History → $4M 3 trades by 3 insiders · 0% under pre-set plans
Net ▼ $4M net selling
Insider Date Trade Shares Price Value
Gabai-Pinsky Veronique Director August 27, 2026 Sell 900 $116.86 $105,174
Jean Madar Holding Sas 10% owner April 2, 2026 Sell 20,000 $91.02 $1.8M
Philippe Benacin Holding Sas 10% owner December 11, 2025 Sell 25,000 $83.24 $2.1M

From insiders' Form 4 filings with the SEC. Excludes awards, option exercises and shares withheld for tax. "Pre-set plan" means the filing marks the trade as made under a Rule 10b5-1 plan. See every insider trade since five years ago, on a price chart.

Earnings dates and SEC filings

Results announcements

  • October 20, 2026
  • August 4, 2026
  • July 22, 2026
  • May 5, 2026
  • April 21, 2026
  • February 24, 2026

Recent SEC filings

Data status

When each part of this page on Interparfums Inc was last updated.

DataLast updatedSource
Share priceExchange closing prices
Financial statementsSEC 10-K and 10-Q filings
News and updatesCompany releases and SEC 8-K filings
Analyst estimatesAggregated analyst estimates
Valuation and scoresOur models, from the filed figures

How we build and check these figures: methodology and data sources.

Interparfums Inc in brief

What does Interparfums Inc do?
Interparfums Inc is a US-listed company in the personal care products industry. Its financial year ends in December.
What is Interparfums Inc's stock ticker?
Interparfums Inc trades under the ticker IPAR on Nasdaq. This page brings together its financial statements, valuation models, ownership and recent company updates.
What is Interparfums Inc's revenue, and how fast is it growing?
Over its most recent trailing twelve months, Interparfums Inc reported revenue of $1.5B, 2.9% higher than a year earlier, according to its SEC filings.
What is Interparfums Inc's free cash flow?
Interparfums Inc's free-cash-flow margin is 16.4% of revenue over the trailing twelve months, ranking 4 of the 21 personal care products companies we cover.
What is Interparfums Inc's fair value (intrinsic value) per share?
Our discounted-cash-flow model of Interparfums Inc's free cash flow after stock-based pay gives ~$100 per share in the base case, and ~$75–$140 across growth scenarios. These are model values under stated assumptions — not a price target or a recommendation.
Who are Interparfums Inc's largest institutional shareholders?
By value reported in 13F filings for June 30, 2026, the largest reported holders are Blackrock, Inc., Morgan Stanley and Vanguard Portfolio Management LLC. 13F reports cover long US-listed positions of managers above $100M, filed up to 45 days after quarter end.
Is Interparfums Inc buying back stock, and does it pay a dividend?
Interparfums Inc spent $15.8M on share repurchases over the trailing twelve months, and its diluted share count fell 0.0% over the year.
What is Interparfums Inc's market cap?
On November 2, 2026, Interparfums Inc's market capitalisation was about $3.8B, with a price-to-earnings ratio of 22.9 and net debt of $0. Market figures come from third-party market data and may be delayed.
Does Interparfums Inc pay a dividend?
Yes: Interparfums Inc paid $103M in dividends over the trailing twelve months, a dividend yield of 2.67% and a payout ratio of 61.2%.
How much debt does Interparfums Inc have?
Interparfums Inc's debt-to-equity ratio is 16.4%, from its latest balance sheet (23.2% five years earlier). The financial health section below sets out its other solvency checks.
Who are Interparfums Inc's competitors?
In our Personal Care Products peer group, the companies closest to Interparfums Inc are NU Skin Enterprises, Inc., E.l.f. Beauty, Inc., Edgewell Personal Care Co, Bellring Brands, Inc. and Usana Health Sciences Inc. The side-by-side comparison below sets their revenue, margins and growth against Interparfums Inc's.
Are insiders buying or selling Interparfums Inc stock?
Over the last 12 months, Interparfums Inc's directors and officers reported 0 open-market purchases and 3 sales on Form 4. The insider trading page charts every trade.
When is Interparfums Inc's next earnings date?
Around November 4, 2026, estimated from the spacing of its past results announcements (8-K filings). That is an estimate, not a confirmed date — Interparfums Inc announces its own schedule.